Navigation Links
Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
Date:9/23/2009

LACHEN, SWITZERLAND and HOBOKEN, N.J., Sept. 23 /PRNewswire/ -- Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.

"We are extremely pleased with the BLA submission for octagam 10% and look forward to advancing Octapharma's firm commitment to providing immune globulin therapy in the U.S. marketplace," said Octapharma USA President Flemming Nielsen. "The expected introduction of octagam 10% will provide yet another immune globulin intravenous (IGIV) product option for patients that further builds on the success already achieved with the octagam product line both globally and in the U.S."

In 2004, Octapharma, one of the largest plasma products manufacturers in the world, gained U.S. approval from the FDA for its IGIV product, octagam(R) (immune globulin intravenous [human] 5%). The therapy, which treats disorders of the immune system, has
'/>"/>

SOURCE Octapharma AG
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
2. Octapharma USA Retains Yankee Public Relations as its Agency of Record
3. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
4. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
5. Octapharma Joins Biotechnology Industry Organization
6. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
7. DIA/FDA/PhRMA Conference To Expand The Role Of Modeling And Simulation In Clinical Drug Development
8. Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
9. PA Helping Life Science Companies Secure Venture Capital Needed to Expand, Gov. Rendell Says
10. Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership
11. OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
(Date:6/18/2013)... 2013 Demanding industrial and environmental conditions ... synthetic Sapphire and Glass Ball Lenses, now available in ... Jewel Company , of Philadelphia , PA. , Optical ... the light beams without the need for direct physical ... durability (9 mohs) make it the ideal choice for ...
(Date:6/18/2013)... 2013 Nasseo, Inc. today announces that ... out of hundreds of applicants by the Arizona ... Innovation Challenge . The Arizona Innovation Challenge (AIC) awards ... commercialization challenge, granting a financial award to what it ... Nasseo’s state of the art dental and orthopedic implant ...
(Date:6/18/2013)... 2013  regulated information — Global biopharmaceutical company UCB, ... announced the launch of a new Pledge campaign for ... The Pledge empowers the millions of Americans ... a personal commitment to demand more: greater understanding of ... and additional partial-onset seizure control.  More information is available ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... June 20, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Company will present data for its two first-in-class ... acetate) injection, and its investigational diabetes drug candidates ... once monthly at the 71st Scientific Sessions of ...
... YORK, June 20, 2011 Clenergen Corporation (OTCQB: ... offers strategic clean energy generation and supply of biomass ... supplies of electricity. They have assembled an experienced managerial, ... levels of existing combustion steam biomass power plants along ...
... renovation of half the space in a key office ... earned the company Leadership in Energy and Environmental Design ... (USGBC). LEED certification is the USGBC,s rating and recognition ... energy efficient, and highest performing buildings. The designation is ...
Cached Biology Technology:Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 2Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 3Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 4Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 5Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 6Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 7Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 8CLENERGEN - One of India's Largest Biomass Power Generating Companies and a Global Specialist in the Cultivation and the Production of Sustainable Biomass Feedstock - is Available for Meetings in New York From June 20th Until June 30th 2CLENERGEN - One of India's Largest Biomass Power Generating Companies and a Global Specialist in the Cultivation and the Production of Sustainable Biomass Feedstock - is Available for Meetings in New York From June 20th Until June 30th 3Roche Building Awarded LEED® Gold Certification 2Roche Building Awarded LEED® Gold Certification 3
(Date:6/19/2013)... YORK , June 19, 2013  New York ... by the United States Patent and Trademark Office for ... systems that reflect whether guards have been injured, attacked ... an extensive portfolio under the Intellectual Properties Agreements of ... Lisa Pamintuan , President of New York ...
(Date:6/19/2013)... Medicines Agency (EMA) approved the modified adeno-associated virus ... for clinical use in the Western world. uniQure, ... for the treatment of a rare inherited metabolic ... approximately one or two out of one million ... the pancreas. Afflicted individuals carry a defect in ...
(Date:6/18/2013)... University of Calgary,s Faculty of Medicine have discovered a ... harmful bacteria. Platelets, a component of blood typically associated ... bacteria, and upon detection, seal it off from the ... in Nature Immunology this week, provide the ... "The science community has known that platelets do participate ...
Breaking Biology News(10 mins):New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4No danger of cancer through gene therapy virus 2Immunity mechanism discovered 2
... disease-causing invader that creates a fuzzy gray coating on ... access to a different type of pathogen. , A ... Austria and North Carolina identified the gene that helps ... disease. The gene and its defense mechanisms are similar ...
... Genome Research , a team of scientists reports that 'mad ... history, nor have been cannibalistic rituals that are known to ... scientist at the Universitat Pompeu Fabra, and his colleagues used ... selection associated with cannibalism has not been a major selective ...
... illegal trade in the Roti Island snake-necked turtle, found only on ... the wild. Exotic pet enthusiasts in Europe, North America and ... without realizing that they are contributing to its demise. No ... , The report by TRAFFIC, the wildlife trade monitoring network ...
Cached Biology News:Gene thwarts some pathogens, gives access to others, could save crops 2Gene thwarts some pathogens, gives access to others, could save crops 3History of human cannibalism eats away at researchers 2Illegal trade is propelling rare turtle toward extinction, new report 2
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is based ... transposition system developed by Goryshin and Reznikoff, ... of nested families of deletions and inversions ... in a transposon-containing plasmid vector. Although most ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
... kit is designed to knockout or alter genes ... than one week. Red/ET recombination allows the exchange ... specific, and faithful manner. An FRT-flanked kanamycin resistance ... can be used to replace a gene on ...
Biology Products: